https://orcid.org/0000-0002-9376-1911
References
- Asmat U, Abad K, Ismail K. 2016. Diabetes mellitus and oxidative stress-A concise review. Saudi Pharm J. 24(5):547–553.
- Kekuda TP, Lavanya D, Pooja R. 2019. Lichens as promising resources of enzyme inhibitors: a review. J Drug Deliv Ther. 9:665–676.
- Lotfi MH, Fallahzadeh H, Rahmanian M, Hosseinzadeh M, Lashkardoost H, Doaei S, Gholamalizadeh M, Hamedi A. 2019. Association of food groups intake and physical activity with gestational diabetes mellitus in Iranian women. J Matern Fetal Neonatal Med. 1–6. https://doi.org/10.1080/14767058.2019.1579189
- Ranković B, Kosanić M. 2019. Lichens as a potential source of bioactive secondary metabolites. In Lichen secondary metabolites. Cham: Springer, p. 1–29.
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE. 2019. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 157:107843.
- Song YH, Uddin Z, Jin YM, Li Z, Curtis-Long MJ, Kim KD, Cho JK, Park KH. 2017. Inhibition of protein tyrosine phosphatase (PTP1B) and α-glucosidase by geranylated flavonoids from Paulownia tomentosa. J Enzyme Inhib Med Chem. 32(1):1195–1202.
- Tatipamula VB, Vedula GS, Sastry A. 2019. Antarvediside A-B from manglicolous lichen Dirinaria consimilis (Stirton) D.D. Awasthi and their pharmacological profile. Asian J Chem. 31(4):805–812.
- Thadhani VM, Karunaratne V. 2017. Potential of lichen compounds as antidiabetic agents with antioxidative properties: a review. Oxid Med Cell Longev. 2017:2079697ID 2079697.
- Verma N, Behera BC, Sharma BO. 2012. Glucosidase inhibitory and radical scavenging properties of lichen metabolites salazinic acid, sekikaic acid and usnic acid. J Biol Chem. 40:7–21.